Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

Bristol Myers Squibb - The Evolving Treatment Landscape for Metastatic Melanoma: A Clinical Lens on Current Decision Making

Considerations for Treatment Selection: A Case-Based Panel Discussion

Date

12 Sep 2022

Session

Bristol Myers Squibb - The Evolving Treatment Landscape for Metastatic Melanoma: A Clinical Lens on Current Decision Making

Topics

Tumour Site

Melanoma

Presenters

Hussein Tawbi

Authors

H.A. Tawbi

Author affiliations

  • Melanoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, 77030 - Houston/US

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Welcome and introduction

Presenter: Paolo Ascierto

Session: Bristol Myers Squibb - The Evolving Treatment Landscape for Metastatic Melanoma: A Clinical Lens on Current Decision Making

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.